Alex Goldberg

Gulfport Energy Corp. (NASDAQ:GPOR) and Galena Biopharma, Inc. (NASDAQ:GALE) Added to Equity Profile Report's NASDAQ Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/06/2014 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Gulfport Energy Corp. (NASDAQ:GPOR) and Galena Biopharma, Inc. (NASDAQ:GALE).

Gulfport Energy Corp. (NASDAQ:GPOR) a company that engages in the exploration, development, and production of oil and natural gas properties closed down in its previous session (-1.76%) on 1,726,402 shares traded. Gulfport Energy Corp. (NASDAQ:GPOR) is currently down (-18.38%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Gulfport Energy Corp. (NASDAQ:GPOR)

Galena Biopharma, Inc. (NASDAQ:GALE) a biopharmaceutical company that focuses on developing oncology treatments to address major unmet medical needs to advance cancer care closed down in its previous session (-2.12%) on 6,881,013 shares traded after TheStreet Quant Ratings rated Galena Biopharma as a sell. Galena Biopharma, Inc. (NASDAQ:GALE) is currently down (-47.88%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Galena Biopharma, Inc. (NASDAQ:GALE)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com